by GlobeNewsWire | Aug 10, 2016 | Globe Newswire
NORTHVALE, N.J., Aug. 10, 2016 (GLOBE NEWSWIRE) — Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB:ELTP) today announced that it has filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration (FDA)...
by GlobeNewsWire | Aug 9, 2016 | Globe Newswire
NORTHVALE, N.J., Aug. 09, 2016 (GLOBE NEWSWIRE) — Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, announced results for the...
by GlobeNewsWire | Jul 15, 2016 | Globe Newswire
NORTHVALE, N.J., July 15, 2016 (GLOBE NEWSWIRE) — Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB:ELTP) today announced that the U.S. Food and Drug Administration (the “FDA”) has issued a Complete Response Letter (the “CRL”)...
by GlobeNewsWire | Jun 15, 2016 | Globe Newswire
Revenues Increased 150% Conference Call Scheduled for Monday, June 20 at 11:00 AM EDT NORTHVALE, N.J., June 15, 2016 (GLOBE NEWSWIRE) — Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB:ELTP), a specialty pharmaceutical...
by editor | Aug 17, 2011 | Latest Spotlights, Medical Stocks
Dallas, Texas (August 17, 2011) – StockGuru Shines its Spotlight on Elite Pharmaceuticals, Inc. (OTCBB: ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral controlled release product formulations and the manufacturing of...